
OncoTICE® (Bacillus Calmette-Guérin [BCG], Strain TICE®) is indicated for: • treatment of primary or relapsing flat urothelial cell carcinoma in situ (CIS) of the urinary bladder
OncoTICE - Uses, Side Effects, Interactions - MedBroadcast.com
OncoTICE: Bacillus Calmette-Guérin (BCG) belongs to the group of cancer-fighting medications known as antineoplastics. BCG is thought to treat cancer in the bladder by stimulating the body's own defense system to attack the cancer cells.
Oncotice generic. Price of oncotice. Uses, Dosage, Side effects
Oncotice drug information: uses, indications, side effects, dosage. Compare prices for generic oncotice substitutes: A BCG vaccine, Bacillus Calmette Guerin Vaccine, Bcg - medac
Before the first intravesical instillation of OncoTICE®, your healthcare professional will probably perform a skin test (Mantoux test) to investigate if you have an active tuberculosis infection. • If a skin test (Mantoux test) is performed after treatment with OncoTICE®, it may be positive.
- [PDF]
OncoTICE - Medsafe
OncoTICE. The use of a condom may protect your partner provided it is used correctly and does not tear. • If a skin test (Mantoux test) is performed after treatment with OncoTICE, it may be positive. • Driving and using machines: There is no warning that your ability to drive or operate machines will be affected. OncoTICE should not be
BCG/Oncotice treatment for bladder cancer
BCG triggers inflammation in the lining of the bladder that destroys cancer cells. If you are attending as an outpatient, the first course of immunotherapy treatment is usually 6 doses at weekly intervals.
Oncotice Drug / Medicine Information - News-Medical.net
2025年3月16日 · OncoTICE is used for the treatment of superficial bladder cancer by stimulating the body's natural ability to fight disease. It is also used to prevent the disease from recurring after bladder ...
ONCOTICE Powder for instillation fluid for intravesical use
OncoTICE is indicated for treatment of primary or concurrent carcinoma-in-situ of the urinary bladder and for the prevention of recurrence of high grade and/or relapsing superficial papillary transitional cell carcinoma of the urinary bladder (Stage Ta (grade 2 or 3) or T1 (grade 1, 2 or 3)) after transurethral resection.
Les instillations intravésicales d'OncoTICE® - HUG
L’OncoTICE® est la préparation d’une souche atténuée de Mycobacterium bovis (bacille de la tuberculose) cultivée pour ses propriétés anti-tumorales. Elle agit en déclenchant une réaction inflammatoire et immunitaire locale visant à réduire, voire empêcher la …
Oncotice: Uses, Dosage, Side Effects, Food Interaction & FAQ
2025年1月7日 · Oncotice is a vaccine indicated in the prevention of tuberculosis and the treatment of non-invasive urothelial bladder cancer.